← Browse by Condition
Medical Condition

myelodysplasia

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07249346 Phase 2
Recruiting

Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation

Enrollment
124 pts
Location
United States
Sponsor
Hannah Choe, MD
View Trial →